Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Mar 19, 2025; 15(3): 101876
Published online Mar 19, 2025. doi: 10.5498/wjp.v15.i3.101876
Enhancing recovery in non-small cell lung cancer patients through mindfulness training and Jinshui Liujun decoction supplementation
Haewon Byeon
Haewon Byeon, Workcare Digital Health Lab, Department of Convergence, Korea University of Technology and Education, Cheonan 31253, South Korea
Author contributions: Byeon H contributed to this paper by designing the study, developing the methodology, interpreting the data, and assisting with writing the article.
Supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, No. RS-2023-00237287.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Haewon Byeon, Associate Professor, PhD, Workcare Digital Health Lab, Department of Convergence, Korea University of Technology and Education, No. 1600 Chungjeol-ro, Cheonan 31253, South Korea. bhwpuma@naver.com
Received: September 29, 2024
Revised: January 3, 2025
Accepted: January 11, 2025
Published online: March 19, 2025
Processing time: 149 Days and 17.7 Hours
Core Tip

Core Tip: This article accentuates the pivotal role of integrating mindfulness-based stress reduction training with flavored Jinshui Liujun decoction alongside conventional chemotherapy in treating non-small cell lung cancer. The study by Liu DW et al demonstrates that this combined treatment significantly enhances immune function, alleviates negative emotions, and improves overall patient outcomes, suggesting a promising adjunctive therapy for non-small cell lung cancer management.